Calcipotriene 0.005% And Betamethasone Dipropionate 0.064% Ointment
Loading...Calcipotriene 0.005% And Betamethasone Dipropionate 0.064% Ointment Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Calcipotriene 0.005% and betamethasone dipropionate 0.064% ointment is indicated for the topical treatment of psoriasis vulgaris in adults 18 years of age and older.
- Calcipotriene 0.005% and betamethasone dipropionate 0.064% ointment should not be applied to the face, axillae or groin.
- Calcipotriene 0.005% and betamethasone dipropionate 0.064% ointment should not be used if there is skin atrophy at the treatment site.
History
There is currently no drug history available for this drug.
Other Information
Calcipotriene 0.005% and betamethasone dipropionate 0.064% ointment contains calcipotriene and betamethasone dipropionate.
It is intended for topical use only.
Calcipotriene is a synthetic vitamin D3 analog.
Chemically, calcipotriene is (5Z,7E,22E,24S)-24-cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1(α),3(β),24-triol, with the empirical formula C27H40O3, a molecular weight of 412.3, and the following structural formula:
Calcipotriene is a white to almost white crystalline compound.
Betamethasone dipropionate is a synthetic corticosteroid.
Betamethasone dipropionate has the chemical name 9-fluoro-11(β),17,21-trihydroxy-16(β)-methylpregna-1,4-diene-3,20-dione17,21-dipropionate, with the empirical formula C28H37FO7, a molecular weight of 504.6, and the following structural formula:
Betamethasone dipropionate is a white to almost white odorless powder.
Each gram of calcipotriene 0.005% and betamethasone dipropionate 0.064% ointment contains 50 mcg of calcipotriene and 0.643 mg of betamethasone dipropionate (equivalent to 0.5 mg of betamethasone) in off-white to yellow paraffin ointment base of caprylic/capric triglycerides, diazolidinyl urea, dl-alpha tocopherol and white petrolatum.
Sources
Calcipotriene 0.005% And Betamethasone Dipropionate 0.064% Ointment Manufacturers
-
Sandoz Inc.
![Calcipotriene 0.005% And Betamethasone Dipropionate 0.064% Ointment [Sandoz Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Calcipotriene 0.005% And Betamethasone Dipropionate 0.064% Ointment | Sandoz Inc.
Apply an adequate layer of calcipotriene 0.005% and betamethasone dipropionate 0.064% ointment to the affected area(s) once daily for up to 4 weeks. The maximum weekly dose should not exceed 100 g. Treatment of more than 30% body surface area is not recommended. Calcipotriene 0.005% and betamethasone dipropionate 0.064% ointment should be rubbed in gently and completely. Patients should wash their hands after applying calcipotriene 0.005% and betamethasone dipropionate 0.064% ointment.
Calcipotriene 0.005% and betamethasone dipropionate 0.064% ointment is not for oral, ophthalmic, or intravaginal use.
Login To Your Free Account